
- Volume 0 0
Lupus Patients: OK to Take the Pill
Doctors have often been hesitant toprescribe oral contraceptives to lupuspatients for fear it might increase diseaseactivity. In a major study fundedby the National Institutes of Health,however, women with either inactiveor stable systemic lupus were able totake "the pill"without increased risk offlares (periods of increased diseaseactivity) that characterize the disease.
In the 15-center study of 183 womenwith inactive or stable lupus, those takingoral contraceptives had no significant differencein the occurrence of flares, comparedwith those taking a placebo.Severe flares occurred in about 7% ofwomen, whether or not they were takingthe pill. Mild-to-moderate flares werealso similar between the 2 groups overthe 12-month follow-up period.
Reluctance to prescribe the pill andother hormones to women with lupusarose partly due to the fact that lupusis more common in women than men(with a 10 to 1 ratio), and that it usuallysets in during childbearing years,when a woman's hormones are at theirpeak. Past models showed that administeringestrogen made the diseaseworse, but, for most women with moderatelupus, taking estrogen in mostforms appears to have no negativeeffect on the disease.
Articles in this issue
almost 20 years ago
can you READ these Rxs?almost 20 years ago
Compounding HOTLINEalmost 20 years ago
A Quarter Century of Pharmacy Law—And the Fat Lady Is Singingalmost 20 years ago
It's Time for Education on Rx Drug Abusealmost 20 years ago
Improving Quality of Life for Psoriasis Patientsalmost 20 years ago
A Look at Diabetic Retinopathyalmost 20 years ago
The Graying of HIValmost 20 years ago
AutoCarouselalmost 20 years ago
Lexi-Comp Knowledge Solutionalmost 20 years ago
Refill TeleManagerNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.















































































































































































































